Medicare plan to verify negotiated drug prices spurs unease

By Bloomberg Law
| May 30, 2024

The Medicare system proposed by the Biden administration to verify negotiated drug prices reach eligible individuals is generating concerns.

subscription required

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...